| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 42.03B | 42.50B | 42.69B | 43.38B | 37.62B | 35.47B |
| Gross Profit | 10.28B | 10.69B | 10.31B | 10.78B | 9.20B | 8.61B |
| EBITDA | 2.28B | 2.24B | 2.72B | 3.30B | 2.21B | 1.90B |
| Net Income | 1.36B | 1.44B | 1.68B | 1.84B | 996.36M | 1.23B |
Balance Sheet | ||||||
| Total Assets | 26.25B | 28.04B | 27.41B | 28.42B | 26.19B | 24.67B |
| Cash, Cash Equivalents and Short-Term Investments | 11.52B | 9.99B | 10.46B | 10.05B | 7.29B | 7.53B |
| Total Debt | 2.25B | 2.08B | 2.36B | 2.39B | 2.65B | 3.13B |
| Total Liabilities | 14.01B | 14.29B | 14.69B | 16.69B | 16.29B | 15.53B |
| Stockholders Equity | 12.18B | 13.75B | 12.67B | 11.68B | 9.86B | 9.11B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | 743.35M | 1.28B | 4.02B | 504.81M | 2.25B |
| Operating Cash Flow | 0.00 | 754.32M | 1.32B | 4.13B | 556.15M | 2.27B |
| Investing Cash Flow | 0.00 | -144.55M | -71.25M | -543.46M | 366.40M | -78.33M |
| Financing Cash Flow | 0.00 | -1.09B | -830.97M | -826.11M | -1.11B | -1.09B |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
74 Outperform | ¥215.11B | 6.47 | 17.09% | 2.94% | 20.29% | 94.13% | |
72 Outperform | ¥59.04B | 14.67 | ― | 4.12% | 6.27% | 31.76% | |
67 Neutral | ¥21.75B | 15.35 | ― | 3.83% | 21.81% | -49.75% | |
64 Neutral | ¥42.10B | 8.77 | ― | 5.16% | 1.23% | -22.74% | |
62 Neutral | ¥12.35B | 9.34 | ― | 4.62% | -0.44% | -13.10% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
59 Neutral | ¥47.11B | 32.39 | 1.55% | 1.34% | -14.56% | 181.24% |